▲ BUY
8
/ 10
Conviction
$ Value
$350K
Shares
60,000
Price
$6
Filed
May 15
▶ Why this score? (8/10)
- ✓ Open market buy (+3)
- ✓ Trade value >= $250K (+1)
- ✓ C-suite insider (+2)
- ✓ Director (+1)
- ✓ Not a 10b5-1 plan (+1)
Insider
Name
PAPA JOSEPH C
Title
President and CEO
CIK
0001242215
Roles
Director
Officer
Transaction Details
Transaction Date
2025-05-13
Code
P
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
342,500
Footnotes
On May 13, 2025, Mr. Papa purchased an aggregate of 60,000 shares of Emergent BioSolutions Inc. common stock. For reporting purposes, purchase prices within a $1 range have been aggregated and the weighted average purchase price has been reported. The price ranges were: $5.76 - $5.88. The Company maintains a record of the transactions and copies will be provided upon request.
Filing Info
PAPA JOSEPH C's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-31 | CADL | A | $11K |
| 2026-03-05 | EBS | F | $313K |
| 2026-03-03 | EBS | A | $0 |
| 2025-07-11 | MIST | A | — |
| 2025-07-11 | MIST | A | — |
| 2025-07-11 | MIST | A | — |
| 2025-06-25 | CADL | A | $300K |
| 2025-06-17 | CADL | A | $0 |
| 2025-06-10 | MIST | A | $0 |
| 2025-05-13 | EBS | ▲ | $350K ★ |
Other Insiders at EBS (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| FOWLER JOHN D JR | — | — | 2026-03-03 |
|
LINDAHL RICHARD S
EVP, Chief Financial Officer
|
— | — | 2026-03-05 |
|
PAPA JOSEPH C
President and CEO
|
— | — | 2026-03-05 |
|
Glessner Coleen
EVP, Quality & Ethics, and CPL
|
— | — | 2026-03-05 |
|
Williams Paul Anthony
SVP, Products Business
|
— | $34K | 2026-04-01 |
|
Hartzel William
SVP, Bioservices
|
— | — | 2026-03-05 |
|
Perl Jessica
SVP, General Counsel, Corp Sec
|
— | — | 2026-03-05 |
|
Lowry Simon C
SVP, R&D, CMO
|
— | — | 2026-03-05 |